Vancouver, BC – August 10, 2017: Liberty Leaf Holdings Ltd. (CSE: LIB, OTCQB: LIBFF and FSE: HN3P) (the “Company” or “Liberty Leaf”) today announced the creation of an Advisory Board for the company, as well as the appointment of Robert W.E. Laurie as Advisory Board Chair.
Mr. Laurie is an international lawyer, writer and speaker, qualified as a solicitor in England and Wales and called to the British Columbia Bar as a barrister and solicitor. After practicing law in London and New York in the areas of hedge fund formation and securities fraud litigation, Mr. Laurie founded AD LUCEM LAW CORPORATION in Vancouver, British Columbia in 2013. Mr. Laurie focuses his legal practice on issues related to cannabis, encompassing the areas of business law, family and administrative litigation, plus criminal defence.
Solid expertise in the cannabis industry
Mr. Laurie is a volunteer lawyer with the Access Pro Bono Society of British Columbia and a Director with Destiny Grow Systems, an organic soil company. Mr. Laurie is also a Contributing Writer and Columnist with ‘Grow Magazine‘, based in Oregon. His regular column with ‘Grow’ is entitled: “North of the 49th Parallel: Cannabis News and Legal Commentary from Canada.” He is also a former Board Advisor to the Canadian Association of Medical Cannabis Dispensaries (CAMCD).
Liberty Leaf’s new Advisory Board Chair holds an M.A. (Hons.) Juris from the University of Oxford (St Edmund Hall) and a B.A. (Hons.) in Political Science and International Relations from the University of British Columbia.
“We at Liberty Leaf are extremely gratified to welcome Robert to the team,” said President and CEO Will Rascan. “His input will add immense depth to our venture as we continue to pursue our aggressive growth plans.”
According to Mr. Laurie, Liberty Leaf is on a fast track to dramatic expansion in the next few years. “I am very excited to be able to bring my unique international experience and cannabis industry insights to bear in this burgeoning enterprise, and I look forward to contributing as much of my expertise as possible.”
Roles and responsibilities
Mr. Laurie’s first objective is to identify and select other Advisory Board members, based on their ability to contribute strategic insight to the company on specific cannabis opportunities and developments.
He explained, “The Advisory Board will assist the Company in many aspects, among them, furthering its distribution business model via its wholly-owned subsidiary, North Road Ventures. The Advisory Board will play an integral role in shaping Liberty Leaf’s cannabis business holdings.”
Liberty Leaf anticipates the announcement of six to eight members to the Advisory Board over the coming months. The members selected will possess abilities and skills related to the cannabis business that are unique in nature and will add value to the company.
Will Rascan elaborated, “The Advisory Board will vet potential business opportunities, discover and conduct due diligence on potential value-added synergistic targets, and foster new relationships that will further our Company’s presence within the global cannabis industry.”
About Liberty Leaf
Liberty Leaf Holdings Ltd. is a new Canadian-based, public company whose focus is to build and support a diversified portfolio of cannabis-sector businesses, including cultivation, value-added CBD/THC products, biotech research and supply chain products within this dynamic and fast-growing sector.
Liberty Leaf also owns 100% of North Road Ventures, a late-stage applicant under Health Canada’s Access to Cannabis for Medical Purposes Regulations (ACMPR).
On behalf of the Board
Will Rascan, President & CEO
Liberty Leaf Holdings Ltd.
Neither the Canadian Securities Exchange nor its Market Regulator (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.
This news release may contain forward-looking statements based on assumptions and judgments of management regarding future events or results. Such statements are subject to a variety of risks and uncertainties which could cause actual events or results to differ materially from those reflected in the forward looking statements. The company disclaims any intention or obligation to revise or update such statements.